Stockscreener 앱 받기
12.99
1.67%
-0.22
전일 마감가:
$13.21
열려 있는:
$13.29
하루 거래량:
116.27K
Relative Volume:
1.05
시가총액:
$345.44M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+3.42%
1개월 성능:
+12.86%
6개월 성능:
+0.62%
1년 성능:
+0.00%
1일 변동 폭
$12.92
$13.91
1주일 범위
$12.55
$15.19
52주 변동 폭
$10.65
$17.19
Carlsmed Inc Stock (CARL) Company Profile
명칭
Carlsmed Inc
전화
858-295-9290
주소
1800 ASTON AVENUE, CARLSBAD
Compare CARL vs VEEV, TEM, BTSG, HQY, WAY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CARL
Carlsmed Inc
|
12.99 | 351.29M | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
188.48 | 30.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
51.29 | 9.19B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
41.96 | 7.33B | 11.99B | 24.18M | 234.31M | 0.2956 |
|
HQY
Healthequity Inc
|
81.15 | 6.87B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
26.93 | 5.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
Carlsmed Inc Stock (CARL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-18 | 개시 | BTIG Research | Buy |
| 2025-08-18 | 개시 | BofA Securities | Buy |
| 2025-08-18 | 개시 | Goldman | Buy |
| 2025-08-18 | 개시 | Piper Sandler | Overweight |
| 2025-08-18 | 개시 | Truist | Buy |
Carlsmed Inc 주식(CARL)의 최신 뉴스
CARL: Personalized spine surgery platform posts 86% annual growth and expands into cervical market - TradingView
CARL: Personalized spine surgery platform drives rapid growth, clinical success, and strong reimbursement - TradingView
Brokerages Set Carlsmed, Inc. (NASDAQ:CARL) Target Price at $21.33 - Defense World
Carlsmed (CARL) versus Its Peers Financial Contrast - Defense World
Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS), Wave Life Sciences (WVE) and Carlsmed, Inc. (CARL) - The Globe and Mail
Carlsmed, Inc. (NASDAQ:CARL) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Carlsmed (NASDAQ:CARL) Lowered to Strong Sell Rating by Zacks Research - MarketBeat
Head to Head Survey: Carlsmed (CARL) versus Its Competitors - Defense World
Carlsmed Q4 2025 revenue up 61% to USD 15.2M - Medical Buyer
Carlsmed Q4 Earnings Call Highlights - MarketBeat
Carlsmed, Inc. Reports Strong Q4 2025 Earnings and Growth Outlook - Intellectia AI
Carlsmed Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Carlsmed Inc (NASDAQ:CARL) Reports Q4 Revenue Beat and Narrower-Than-Expected Loss - ChartMill
Earnings call transcript: Carlsmed reports strong revenue, stock dips Q4 2025 - Investing.com
Carlsmed (NASDAQ:CARL) Issues Quarterly Earnings Results - MarketBeat
CARL: 2025 revenue surged 86% with expanding margins and strong adoption of new spine surgery products - TradingView
CARL: 2025 revenue surged 86% with expanding margins; 2026 guidance targets $70–$75M and robust growth - TradingView
Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results - The Manila Times
Carlsmed, Inc. Provides Revenue Guidance for the Year 2026 - marketscreener.com
Head to Head Comparison: Carlsmed (CARL) versus Its Competitors - Defense World
Carlsmed announces clinical debuts of two spinal surgery solutions - Today's Medical Developments
Carlsmed Reports Fourth Quarter and Full Year 2025 Financial Results - Bitget
Carlsmed Unveils Custom Cervical Plating Tech - National Today
Carlsmed Inc expected to post a loss of 43 cents a shareEarnings Preview - TradingView
Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference - marketscreener.com
Head to Head Survey: Carlsmed (NASDAQ:CARL) & Check-Cap (NASDAQ:MBAI) - Defense World
Financial Contrast: Carlsmed (CARL) and Its Competitors - Defense World
Carlsmed Announces first corra™ personalized Cervical Plating Procedure - Orthopedics This Week
Carlsmed Announces first corra personalized Cervical Plating Procedure - Bitget
Analyzing Carlsmed (CARL) & Its Competitors - Defense World
CARL Should I Buy - Intellectia AI
Wall Street Zen Upgrades Carlsmed (NASDAQ:CARL) to “Hold” - Defense World
Financial Review: Carlsmed (CARL) versus Its Rivals - Defense World
Critical Comparison: Carlsmed (NASDAQ:CARL) vs. TransEnterix (OTCMKTS:TRXDW) - Defense World
Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - The Manila Times
Carlsmed completes first surgery using aprevo bilateral posterior system By Investing.com - Investing.com Canada
Carlsmed completes first surgery using aprevo bilateral posterior system - Investing.com Nigeria
Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure - Orthopedics This Week
Both private equity firms who control a good portion of Carlsmed, Inc. (NASDAQ:CARL) along with institutions must be dismayed after last week's 11% decrease - simplywall.st
TD Waterhouse Canada Inc. Takes $2.03 Million Position in Carlsmed, Inc. $CARL - MarketBeat
Teacher Retirement System of Texas Purchases Shares of 175,000 Carlsmed, Inc. $CARL - MarketBeat
Financial Comparison: Carlsmed (NASDAQ:CARL) & ReShape Lifesciences (OTCMKTS:RSLSD) - Defense World
Bullish Carlsmed Insiders Loaded Up On US$8.10m Of Stock - Yahoo Finance
Analyzing Carlsmed (NASDAQ:CARL) and Perspective Therapeutics (NASDAQ:CATX) - Defense World
Carlsmed (NASDAQ:CARL) Downgraded to Sell Rating by Wall Street Zen - MarketBeat
BTIG Reiterates Buy Rating on CARL, Maintains Price Target | CAR - GuruFocus
AI medtech firm Carlsmed prices $100.5M IPO - MSN
California-based Carlsmed Q4 2025 revenue up 61% to USD 15.2M - Medical Buyer
Carlsmed reports 61% revenue growth in Q4 2025 By Investing.com - Investing.com Nigeria
Carlsmed Inc (CARL) 재무 분석
Carlsmed Inc (CARL)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Carlsmed Inc 주식 (CARL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Cordonnier Michael | CEO, President |
Mar 02 '26 |
Option Exercise |
0.34 |
197,855 |
66,281 |
1,554,501 |
| Cordonnier Michael | CEO, President |
Mar 02 '26 |
Sale |
13.29 |
197,855 |
2,629,889 |
1,356,646 |
0.25%
1.11%
자본화:
|
볼륨(24시간):